DekaBank Deutsche Girozentrale’s Revolution Medicines RVMD Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.62M	Hold	50,000	–	–	0.01%	564
2026 Q1	$4.71M	Hold	50,000	–	–	0.01%	565
2025 Q4	$1.72M	Hold	50,000	–	–	﹤0.01%	791
2025 Q3	$2.28M	Hold	50,000	–	–	﹤0.01%	725
2025 Q2	$1.83M	Hold	50,000	–	–	﹤0.01%	759
2025 Q1	$1.81M	Hold	50,000	–	–	﹤0.01%	746
2024 Q4	$2.17M	Hold	50,000	–	–	﹤0.01%	727
2024 Q3	$2.19M	Hold	50,000	–	–	﹤0.01%	739
2024 Q2	$1.92M	Hold	50,000	–	–	﹤0.01%	772
2024 Q1	$1.58M	Hold	50,000	–	–	﹤0.01%	800
2023 Q4	$1.46M	Hold	50,000	–	–	﹤0.01%	835
2023 Q3	$1.42M	Hold	50,000	–	–	﹤0.01%	811
2023 Q2	$1.31M	Hold	50,000	–	–	﹤0.01%	834
2023 Q1	$1.06M	Buy	50,000 +26,200	+110%	+$645K	﹤0.01%	861
2022 Q4	$564K	Hold	23,800	–	–	﹤0.01%	1010
2022 Q3	$459K	Hold	23,800	–	–	﹤0.01%	1062
2022 Q2	$445K	Hold	23,800	–	–	﹤0.01%	1037
2022 Q1	$609K	Buy	23,800 +2,200	+10%	+$47.9K	﹤0.01%	1023
2021 Q4	$559K	Buy	21,600 +600	+3%	+$16.9K	﹤0.01%	1074
2021 Q3	$584K	Hold	21,000	–	–	﹤0.01%	1018
2021 Q2	$662K	Hold	21,000	–	–	﹤0.01%	1002
2021 Q1	$918K	Hold	21,000	–	–	﹤0.01%	924
2020 Q4	$842K	Buy	+21,000	New	+$830K	﹤0.01%	913

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

DekaBank Deutsche Girozentrale's RVMD Position: Q2 2026 in Review

DekaBank Deutsche Girozentrale held its Revolution Medicines (RVMD) position steady in Q2 2026 at 50,000 shares worth $4.62M. The position accounts for 0.01% of the portfolio, ranked #564.

DekaBank Deutsche Girozentrale first reported a position in RVMD in Q4 2020 and has held it in 23 quarters since. The position peaked at $4.71M in Q1 2026. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

DekaBank Deutsche Girozentrale held 50,000 shares of Revolution Medicines worth $4.62M as of Q2 2026.
DekaBank Deutsche Girozentrale left its Revolution Medicines share count unchanged in Q2 2026.
Revolution Medicines made up 0.01% of DekaBank Deutsche Girozentrale's portfolio in Q2 2026, its #564 holding.
DekaBank Deutsche Girozentrale first reported a position in Revolution Medicines in Q4 2020 and has held it in 23 quarters since.
DekaBank Deutsche Girozentrale's Revolution Medicines position peaked at $4.71M in Q1 2026.
694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2026, filed 5 Aug 2026.